e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Scientific advances in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Autophagy modulation by
Mycobacterium tuberculosis in vitro
infection of macrophages
E. Petruccioli, A. Romagnoli, O. Butera, I. Palucci, G. Delogu, G. M. Fimia, D. Goletti (Rome, Italy)
Source:
Annual Congress 2010 - Scientific advances in tuberculosis
Session:
Scientific advances in tuberculosis
Session type:
Thematic Poster Session
Number:
5013
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Petruccioli, A. Romagnoli, O. Butera, I. Palucci, G. Delogu, G. M. Fimia, D. Goletti (Rome, Italy). Autophagy modulation by
Mycobacterium tuberculosis in vitro
infection of macrophages. Eur Respir J 2010; 36: Suppl. 54, 5013
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Persistent M. tuberculosis infection: experimental model of endogenously re-activated TB
Source: Eur Respir J 2002; 20: Suppl. 38, 582s
Year: 2002
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Apoptosis plays a protective role against Mycobacterium avium infection in mice
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Increased cell expression of CCR5 during M. tuberculosis infection
Source: ISSN=ISSN 1810-6838, ISBN=, page=177
Year: 2005
Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Effect of persistent mycobacterium avium complex infection on serum vitamin D status and its regulating factors
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Mycobacterium tuberculosis reside only inside phagosomes in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Impaired host defense against
Mycobacterium avium
in mice with chronic granulomatous disease
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
Immunological differences between lung tuberculosis and latent tuberculosis infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
IL-4 subverts mycobacterial containment in
Mycobacterium tuberculosis
-infected human macrophages
Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Year: 2019
Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept